János Banai

Zrínyi Miklós National Defence University — Hungary

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index1.3kcitations78works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(25), Microscopic Colitis(22), Gastrointestinal disorders and treatments(13), Esophageal and GI Pathology(11), Helicobacter pylori-related gastroenterology studies(8)

Publications78 total

Subjective expectations regarding longevity and future health: a cross‐sectional survey among patients with Crohn's disease
Colorectal Disease·2020· 6 citedOpen Access
Patient and general population values for luminal and perianal fistulising Crohn’s disease health states
The European Journal of Health Economics·2019· 9 citedOpen Access
PGI50 - HAPPY TOMORROW BUT GLOOMING ELDERLY? SELF-ESTIMATION OF FUTURE HEALTH IN CROHN’S DISEASE
Value in Health·2018
PRM185 - COMPARISON OF THE MEASUREMENT PROPERTIES OF THE EQ-5D-5L AND EQ-5D-3L IN PATIENTS WITH CROHN’S DISEASE
Value in Health·2018Open Access
Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease
Quality of Life Research·2018· 60 citedOpen Access
Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort
Inflammatory Bowel Diseases·2017· 56 citedOpen Access
Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort
Expert Opinion on Drug Safety·2017· 28 citedOpen Access
P739 Characteristic of IBD related colorectal cancers observed in different Hungarian centers
Journal of Crohn s and Colitis·2017Open Access
Frequency and characteristics of infusionreactions during biosimilar infliximab treatment ininflammatory bowel diseases: results from CentralEuropean nationwide cohort
2017
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection
Gastroenterology·2016· 320 citedOpen Access
OP003. Predicting short and medium-term efficacy of the biosimilar infliximab: trough levels/do anti-drug antibody’s or clinical/biochemical markers play a more important role?
Journal of Crohn s and Colitis·2016Open Access
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort
Journal of Crohn s and Colitis·2015· 182 citedOpen Access
Endoscopic needle-knife stricturoplasty in Esophageal Crohn's Disease – Case report
Zeitschrift für Gastroenterologie·2015
Biosimilar Infliximab in inflammatory bowel diseases: First interim results from a prospective nationwide observational cohort
Zeitschrift für Gastroenterologie·2015· 14 cited
Sa1794 Recurrence Rate After Uncomplicated Diverticulitis and Evaluation of Risk Factors for Relapses After an Attack of Uncomplicated Diverticulitis
Gastroenterology·2015
P314. Biosimilar infliximab in inflammatory bowel diseases: first interim Results from a prospective nationwide observational cohort
Journal of Crohn s and Colitis·2015· 3 citedOpen Access
<i>Clostridium difficile</i>infection: epidemiology, disease burden and therapy
Orvosi Hetilap·2013· 2 cited
Antimicrobial therapy of<i>Clostridium difficile</i>infection. Systematic literature review and meta-analysis
Orvosi Hetilap·2013· 1 cited
Customised nutrition therapy in the treatment of Crohn's disease-related malignant bowel diseases
Zeitschrift für Gastroenterologie·2013
808 Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial of Mesalamine for the Prevention of Recurrence of Diverticulitis
Gastroenterology·2013· 16 cited
page 1 of 4Next →

Frequent Co-authors

Péter L. Lakatos(30), Károly Palatka(15), Mária Papp(12), Á Salamon(12), Pál Miheller(11), I Szántó(11), Áron Vincze(10), Ferenc Nagy(10), Tamás Molnár(10), Tamás Szamosi(9), Z Czeglédi(8), Klaudia Farkas(7), László Bene(7), Beáta Gasztonyi(7), Tünde Kristóf(7), T Szamosi(7), I Rózsa(7), Barbara D. Lovász(6), Petra A. Golovics(6), Zsolt Tulassay(6)